234 related articles for article (PubMed ID: 11811549)
1. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.
Childs LM; Paschalis EP; Xing L; Dougall WC; Anderson D; Boskey AL; Puzas JE; Rosier RN; O'Keefe RJ; Boyce BF; Schwarz EM
J Bone Miner Res; 2002 Feb; 17(2):192-9. PubMed ID: 11811549
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
[TBL] [Abstract][Full Text] [Related]
3. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
[TBL] [Abstract][Full Text] [Related]
4. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
5. Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing.
Flick LM; Weaver JM; Ulrich-Vinther M; Abuzzahab F; Zhang X; Dougall WC; Anderson D; O'Keefe RJ; Schwarz EM
J Orthop Res; 2003 Jul; 21(4):676-84. PubMed ID: 12798068
[TBL] [Abstract][Full Text] [Related]
6. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Schwarz EM; Lu AP; Goater JJ; Benz EB; Kollias G; Rosier RN; Puzas JE; O'Keefe RJ
J Orthop Res; 2000 May; 18(3):472-80. PubMed ID: 10937636
[TBL] [Abstract][Full Text] [Related]
8. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
Ren W; Li XH; Chen BD; Wooley PH
J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
[TBL] [Abstract][Full Text] [Related]
9. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone.
Whang PG; Schwarz EM; Gamradt SC; Dougall WC; Lieberman JR
J Orthop Res; 2005 Nov; 23(6):1475-83. PubMed ID: 16005175
[TBL] [Abstract][Full Text] [Related]
10. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
Sordillo EM; Pearse RN
Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
[TBL] [Abstract][Full Text] [Related]
11. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis.
Schwarz EM; Benz EB; Lu AP; Goater JJ; Mollano AV; Rosier RN; Puzas JE; Okeefe RJ
J Orthop Res; 2000 Nov; 18(6):849-55. PubMed ID: 11192243
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
13. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.
Zhang J; Dai J; Yao Z; Lu Y; Dougall W; Keller ET
Cancer Res; 2003 Nov; 63(22):7883-90. PubMed ID: 14633717
[TBL] [Abstract][Full Text] [Related]
15. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of etanercept for wear debris-induced osteolysis.
Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Feb; 16(2):338-47. PubMed ID: 11204434
[TBL] [Abstract][Full Text] [Related]
20. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
